NCT01978964View on ClinicalTrials.gov

Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Solid Tumors
Interventions
BIOLOGICAL

ONT-10

ONT-10 is a liposomal synthetic glycopolypeptide antigen formulated with PET Lipid A adjuvant

Trial Locations (1)

75201

Mary Crowley Cancer Research Centers, Dallas

Sponsors
All Listed Sponsors
lead

Cascadian Therapeutics Inc.

INDUSTRY

NCT01978964 - Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors | Biotech Hunter | Biotech Hunter